Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 1/2002

01-01-2002

Assessment of Safety and the Immune Response to the CD4 “Internal Antigen” Mouse Anti-Idiotypic MAb 16D7 in Four Patients with SLE

Authors: Federico Perosa, Grazia Luccarelli, Marco Scudeletti, Maurizio Cutolo, Franco Indiveri, Franco Dammacco

Published in: Journal of Clinical Immunology | Issue 1/2002

Login to get access
Metadata
Title
Assessment of Safety and the Immune Response to the CD4 “Internal Antigen” Mouse Anti-Idiotypic MAb 16D7 in Four Patients with SLE
Authors
Federico Perosa
Grazia Luccarelli
Marco Scudeletti
Maurizio Cutolo
Franco Indiveri
Franco Dammacco
Publication date
01-01-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Clinical Immunology / Issue 1/2002
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1023/A:1014200418560

Other articles of this Issue 1/2002

Journal of Clinical Immunology 1/2002 Go to the issue

OriginalPaper

Cervical Concentrations of Interleukin-10 and Interleukin-12 Do Not Correlate with Plasma Levels

OriginalPaper

The Case Definition of Chronic Fatigue Syndrome

OriginalPaper

Rifampicin Inhibits CD95-Mediated Apoptosis of Jurkat T Cells via Glucocorticoid Receptors by Modifying the Expression of Molecules Regulating Apoptosis

Announcement

Announcement: 10th International Congress on Antiphospholipid Antibodies

OriginalPaper

HLA-Cw7 Zygosity Affects the Size of a Subset of CD158b+ Natural Killer Cells

OriginalPaper

CD28 Function: A Balance of Costimulatory and Regulatory Signals
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits